β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer

• Asıl Yazarlar: Mengjie Wang (Yazar), Yu Bai (Yazar), Jiaxin Pei (Yazar), Dongqing Li (Yazar), Xiaolin Pu (Yazar), Wenyu Zhu (Yazar), Lei Xia (Yazar), Chunjian Qi (Yazar), Hua Jiang (Yazar), Yongling Ning (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Programmed death-1 (PD-1)/PD-ligand 1 (PD-L1) checkpoint blocking antibodies have been shown to be a powerful immune checkpoint blockade (ICB) therapy for patients with cancer. However, patients quickly develop resistance to immunotherapy. β-glucan, an immune adjuvant, has been found to stimulate in...